XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Deals of the day-Mergers and acquisitions



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Deals of the day-Mergers and acquisitions</title></head><body>

Adds Petrobras, Envestnet, Metro Bank; Updates Eli Lilly, Masimo

July 8 (Reuters) -The following bids, mergers, acquisitions and disposals were reported by 1945 GMT on Monday:


** Brazilian logistics firm Transpetro, a unit of state-run oil firm Petrobras PETR4.SA, said it has launched a procurement notice to commission four new coastal vessels, which it hopes will help revive the nation's shipbuilding sector.nL1N3J00U8


** Private equity firm Bain Capital is nearing a deal to acquire Envestnet ENV.N, a U.S. financial software vendor with a market value of about $3.5 billion, people familiar with the matter said. nL1N3J00SK


** British lender Metro Bank MTRO.L said it was in talks about a potential disposal of residential mortgage loans worth billions of pounds. nL4N3J018G


** Masimo MASI.O said a potential joint venture partner is prepared to offer $850 million to $950 million for its consumer business, which includes health and audio products. [nL4N3J0106]


** Skydance Media and Paramount Global PARA.O agreed to merge, the companies announced late on Sunday, scripting a new chapter for one of Hollywood's oldest studios. nL1N3IZ075


** Devon Energy DVN.N said it had entered into a deal to acquire private equity firm EnCap-owned Grayson Mill Energy's Williston basin business in a cash-and-stock deal worth $5 billion, as it aims to cash in on high stock valuations to grow acreage. nL4N3J00T0


** Vista Outdoor VSTO.N rejected investment firm MNC Capital's final buyout offer of $3.2 billion, citing that it undervalued the company, and said it had agreed to an increased bid for its ammunition unit from Czechoslovak Group (CSG).nL4N3J00OM


** Eli Lilly LLY.N agreed to buy Morphic Holding MORF.O for $3.2 billion in cash, the companies said, beefing up its portfolio of inflammatory bowel disease (IBD) drugs and expanding its footprint in the multi-billion dollar market.nL4N3J00R3


** UK's competition regulator said it has cleared U.S. medical equipment maker Thermo Fisher Scientific's TMO.N $3.1 billion deal to buy Swedish biotech firm Olink Holding AB OLK.O. nL4N3J00Q1


** Carlsberg CARLb.CO has agreed to buy British soft drinks maker Britvic BVIC.L for 3.3 billion pounds ($4.23 billion), a move the Danish brewer said would forge a UK beverage "powerhouse" and that sent both companies' shares higher. nL4N3J00DT


** The Grifols family and Canadian fund Brookfield have agreed to launch a joint takeover bid for Spanish drugmaker Grifols GRLS.MC with the intent to delist it, the companies said in regulatory filings. nL1N3J0081


** Attica Bank BOAr.AT, Greece's fifth largest lender, announced an initial agreement to merge with the smaller Pancretan Bank in an effort to clean up its balance sheet and create a new banking organisation. nL8N3IW0M6


(Compiled by Rajarshi Roy, Christy Santhosh and Granth Vanaik in Bengaluru)

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.